Mubeen Memon, MD
Psychiatry · Monroe, MINPI 1568440774
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 247 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,598, more than ten times the $159 reported in 2019. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 247 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$868
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$543
- Teva Pharmaceuticals USA, Inc.$477
- Lundbeck LLC$472
- Supernus Pharmaceuticals, Inc.$460
- Alkermes, Inc.$375
- plus $2K from 16 others
What the payments were for
- Food & beverage$4,97799%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $868 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $543 |
| Teva Pharmaceuticals USA, Inc. | 27 | $477 |
| Lundbeck LLC | 25 | $472 |
| Supernus Pharmaceuticals, Inc. | 8 | $460 |
| Alkermes, Inc. | 14 | $375 |
| E.r. Squibb & Sons, L.L.C. | 19 | $324 |
| Otsuka America Pharmaceutical, Inc. | 18 | $321 |
| Corium, LLC | 13 | $263 |
| Axsome Therapeutics, Inc. | 13 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $197 |
| Neurocrine Biosciences, Inc. | 5 | $113 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| Tris Pharma Inc | 4 | $63 |
| Eisai Inc. | 2 | $55 |
| Beigene USA, Inc. | 1 | $49 |
| Neuronetics, Inc. | 2 | $36 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $19 |
| Novo Nordisk | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Exact Sciences | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$308
How this compares
$5,024 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 106 | $10,452 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 48 | $2,053 |
| Methylphenidate ErMethylphenidate Hcl | 33 | $2,052 |
| Paliperidone ErPaliperidone | 11 | $921 |
| Quetiapine Fumarate | 90 | $867 |
| Buspirone Hcl | 79 | $851 |
| Fluoxetine Hcl | 40 | $692 |
| Duloxetine Hcl | 72 | $673 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 33 | $653 |
| Ziprasidone Hcl | 21 | $619 |
| Bupropion XlBupropion Hcl | 30 | $531 |
| Lamotrigine | 74 | $527 |
| Olanzapine OdtOlanzapine | 22 | $513 |
| Olanzapine | 20 | $508 |
| Divalproex Sodium | 22 | $424 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Monroe
- Manzar RajputMonroe$612K
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
- Samuel WedesLivonia$158K
- Arash JavanbakhtDetroit$102K
- Theodore RuzaWest Bloomfield$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.